Thermo Fisher Scientific Inc., Agilent Technologies, Inc. and PerkinElmer Inc. are dominating the Global Solid Phase Extraction Market in the year 2019

Global solid phase extraction market is expected to reach USD 429,736.98 thousand by 2026 from USD 282,686.75 thousand in 2018, at a CAGR of 5.4% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below.

Access Full Report at https://databridgemarketresearch.com/reports/global-solid-phase-extraction-market/

The global solid phase extraction market is a highly concentrated market which includes key players and local players. The market has witnessed increased various strategic developments owing to favourable market scenario. The market has a prominent growth in upcoming years due to rising demand for technological advancements and high investment towards automation of SPE and growing demand of biological fluids tests due to increasing health related issues.

The market has witness developments in terms of merger and acquisitions, partnerships or product launches to enhance the product portfolio to meet the rising demand of innovative technology. For instance In February 2018, Agilent Technologies Inc., launched two new gas chromatography systems that will initiate innovative and intelligent self-aware predictive technology and also help in expanding their portfolio of GC instruments. It will also help the customers by expanding their system intelligent functions.

Thermo Fisher Scientific Inc. has dominated the global solid phase extraction market and accounts for the highest market share in 2018 which is followed by the Agilent Technologies, Inc., PerkinElmer Inc. The other key players existing in the market includes Nippon Paint Holdings Co., Ltd, PerkinElmer Inc., S*Pure Pte Ltd, BIOTAGE, GL SCIENCES INC., GERSTEL GMBH & CO.KG., WATERS, 3M, MERCK & CO.,INC.,  JASCO, Phenomenex Inc., SHIMADZU CORPORATION and others.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. headquartered in Massachusetts, U.S. was founded in 2006. The company mainly accelerates towards life science challenges and research improving the diagnostics by providing medicines and laboratory productivity services. The company operates through four business segments which include analytical instruments, life science solutions, specialty diagnostics and laboratory products & services.

The life science solutions segment which is market focused segment is consisted of the cell analysis and antibodies, cloning, DNA & RNA purification, stem cell research and many more.  Analytical instruments segment broad range of products from consumables, instruments, software and services for laboratories. Specialty diagnostics segment consists of culture media, diagnostic test kits, instruments and related products. Laboratory Products and Services segment has products for pharmaceutical and biotech laboratory. The life sciences solutions segment generated revenue of USD 6,269 million in 2018 and has witnessed decline in growth by 1.7% as compared to the revenue of USD 5,728 million generated in 2017. It is due to the increasing cost of the raw materials in the life science products.

The company has its global networks in the Asia-Pacific, Europe and North America. It operates through its subsidiaries such as Dionex (U.S.), Patheon (Netherlands), Affymetrix (U.S.), FEI Company (U.S.), Cole-Parmer (U.S.), etc.

Agilent Technologies, Inc.

Agilent Technologies, Inc., company is headquartered in California, U.S. was founded in 1999. The company is engaged in providing instruments, services, consumables in life sciences, diagnostics and applied chemical markets. The company operates through three business segments which include Life Science & Applied Markets, Diagnostics & Genomics and Agilent CrossLab.

The life science & applied markets which is market focused segment mainly deals with liquid chromatography, mass spectrometry systems, gas mass spectrometry systems, inductively coupled plasma mass spectrometry systems, atomic absorption instruments, Raman spectroscopy, cell analysis plate based assays, flow cytometry and others. Diagnostics and genomics business offers pathology, companion diagnostics, reagent partnership, genomics, nucleic acid contract manufacturing, research and development and biomolecular analysis businesses. Agilent CrossLab business includes extensive consumables and services portfolio such as sample preparation products, GC and LC columns and other laboratory instrument supplies. The life science & applied markets segment generated revenue of USD 2,270 million in 2018 and has witnessed growth by 9.08% as compared to the revenue of USD 2,081 million generated in 2017. The growth is because of the high demand in the healthcare industry for the analysis of the biological fluids and carrying out the pharmaceutical experiments.

  • In February, Agilent Technologies Inc., launched two new gas chromatography systems that will initiate innovative and intelligent self-aware predictive technology and also help in expanding their portfolio of GC instruments. It will also help the customers by expanding their system intelligent functions.

The company has its global networks through direct sales representatives and distributors in Americas, Asia-Pacific and Europe. It operates through its subsidiaries such as Advanced Analytical Technologies, Inc. (U.S.), ACEA BIO (U.S.), Genohm (Switzerland), Multiplicom N.V. (U.S.), Cobalt Light Systems (U.S.), Seahorse Bioscience (U.S.).

PerkinElmer Inc.

PerkinElmer Inc. is headquartered in Massachusetts, U.S. founded in 1947. The company is engaged in deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. The company operates through three business segments which include Diagnostics, Life Sciences, Applied markets.

The applied market which is market focused segment develop and provide analytical technologies, solutions and services that enable customers to understand the characterisation of air, water and soil. The applied markets segment generated revenue of USD 758.52 million in 2018 and has witnessed growth by 10.72% as compared to the revenue of USD 685.02 million generated in 2017. It was due to the growing demand of extraction required in environmental, food and industrial markets and also due to various product launches under this segment.

The company has its global networks in Asia-Pacific, Europe, North America, South America, and Middle East & Africa. The company has various subsidiaries such as PerkinElmer Optoelectronics GmbH & Co. KG (Germany), PerkinElmer Cellular Technologies Germany GmbH (Germany) and others.